A Comprehensive Literature Review of Allergic Conjunctivitis
Abstract
Allergic disease is a complex disease caused by a combination of genetic and environmental factors. Allergic diseases are on the rise, affecting about 30% to 40% of the world's population. In addition to a decrease in quality of life, this disease can affect thesocial and economic. This study aims to determine the concept of allergic conjunctivitis and its current management. Results: Allergic conjunctivitis is an inflammatory response of the conjunctiva to allergens such as pollen, environmental antigens (eg dust), and animal dander. Conclusion: Allergic diseases can be managed strategically, both non-pharmacologically and pharmacologically. Pharmacological use is usually preferred when non-pharmacological methods prove ineffective or insufficient in reducing allergy symptoms. Topical therapy consists of combination drugs such as antihistamines and vasoconstrictors, or antihistamines with mast cell stabilizing properties. The first are vasoconstrictors that target eye redness and antihistamines that target allergy symptoms.
Keywords: Allergic Conjunctivitis, Concept, Drugs
Keywords:
Allergic Conjunctivitis, Concept, DrugsDOI
https://doi.org/10.22270/jddt.v12i1-S.5300References
Tamari M, Shota Tanaka, Hirota T. Genome-wide association studies of allergic diseases. Allergology International, 2013; 62(1):pp.21-28. https://doi.org/10.2332/allergolint.13-RAI-0539
Van der Poel L, Warner J. Pediatric allergy in review. Pediatrics and Child Health. 2012; 22(7):259-263. https://doi.org/10.1016/j.paed.2012.02.002
Prescott S. (2013). Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol. 2013 Jan; 131(1):23-30. https://doi.org/10.1016/j.jaci.2012.11.019
Akdis M, Akdis C. (2013). Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014 Mar; 133(3):621-31 https://doi.org/10.1016/j.jaci.2013.12.1088
Vally M, Irhuma MOE. Allergic conjunctivitis. South African Family Practice, 2017; 59(5). https://doi.org/10.4102/safp.v59i5.4744
Bieber T. Atopic dermatitis. Ann Dermatol. 2010; 22(2):125-137. https://doi.org/10.5021/ad.2010.22.2.125
Sinigaglia F, D'Ambrosio D, Rogge L. Type I interferons and the Th1/Th2 paradigm. Developmental and Comparative Immunology. 1999; 23(7-9):657-663. https://doi.org/10.1016/S0145-305X(99)00039-7
Alvarez Zallo N, Aguinaga-Ontoso I, Alvarez-Alvarez I, Guillén-Grima F, Azcona San Julian C. The influence of gender and atopy in the relationship between obesity and asthma in childhood. Allergologia et Immunopathologia. 2017; 45(3):227-233. https://doi.org/10.1016/j.aller.2016.09.005
Brunton L, Chabner B, Knollman B. (Editors). Goodman and Gilman's The Pharmacological Basis of Therapeutics. Twelth Edition. New York: McGraw-Hill Medical Publishing Division. 2011.
Lu T, Rothenberg M. (2013). Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol. 2013 Jul; 132(1):3-13 https://doi.org/10.1016/j.jaci.2013.04.039
Tang R, Chang J, Chen H. Can probiotics be used to treat allergic diseases? Journal of the Chinese Medical Association. 2015; 79(3):154-157. https://doi.org/10.1016/j.jcma.2014.08.015
Marko M, Pawliczak R. The role of microbiota in allergy development. Allergologia Polska - Polish Journal of Allergology. 2017; 13. https://doi.org/10.1016/j.alergo.2017.03.002
Strachan D. Hay fever, hygiene, and household size. BMJ. 1999; 299(6710): 1259-1260. https://doi.org/10.1136/bmj.299.6710.1259
Brown E, Arrieta M, Finlay B. A fresh look at the hygiene hypothesis: How intestinal microbial exposure drives immune effector responses in atopic disease. Seminars in Immunology. 2013; 25(5):379-397. https://doi.org/10.1016/j.smim.2013.09.003
Trubo R. Seasonal ocular allergy: new options for a recurring problem. Cornea. 2015 Mar: 31-3.
Bielory BP, O'Brien T, Bielory L. Management of seasonal allergic conjuctivitis: a guide to therapy. Acta Ophthalmologica. 2012; 90:399-407. https://doi.org/10.1111/j.1755-3768.2011.02272.x
Australasian Society of Clinical Immunology and Allergy. Sinusitis and allergies. Balgowlah, 2015; 1-3.
Brenner GM, Stevens CW. Pharmacology. Fourth Edition. China: Elsevier Saunders. 2013.
Matsushita K, Kato Y, Akasaki S, Yoshimoto T. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases. 2017
Okubo K, Kurono Y, Ichimura K, et al. Japanese Guidelines for Allergic Rhinitis 2017. https://doi.org/10.1016/j.alit.2016.11.001
Shah A. (2014). Allergic rhinitis, chronic rhinosinusitis and nasal polyposis in Asia Pacific: impact on quality of life and sleep. Asia Pacific Allergy 2014; 4(3): 131-133 https://doi.org/10.5415/apallergy.2014.4.3.131
Schubert M. Allergic fungal sinusitis: pathophysiology, diagnosis and management. Medical Mycology, 2009; 47(s1):S324-S330. https://doi.org/10.1080/13693780802314809
Rosenfeld R, Piccharillo J, Chandrasekhar S, et al. Clinical Practice Guideline (Update): Adult Sinusitis. Otolaryngology-Head and Neck Surgery, 2015; 152(2_suppl):S1-S39. https://doi.org/10.1177/0194599815572097
Bae J, Choi Y, Park C, Chung K, Lee K. Efficacy of allergen-specific immunotherapy for atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials. 2017
Carr W, Schaeffer J, Donnenfeld E. Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief. Allergy and Rhinology (Providence, R.I.), 2016; 7(2):107-114. https://doi.org/10.2500/ar.2016.7.0158
Published
Abstract Display: 659 
PDF Downloads: 672 PDF Downloads: 106 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.